| P50 | author | Ronald C. Petersen | Q56839853 |
| | David S Knopman | Q63967707 |
| | Bradley F Boeve | Q67501037 |
| | Jennifer L Whitwell | Q99637904 |
| | Val J. Lowe | Q107200019 |
| | Matthew L Senjem | Q30505707 |
| | Clifford Jack | Q30505709 |
| P2093 | author name string | K A Josephs | |
| | F Ali | |
| | P R Martin | |
| P2860 | cites work | [18F]AV-1451 tau-PET uptake does correlate with quantitatively measured 4R-tau burden in autopsy-confirmed corticobasal degeneration | Q48505309 |
| | Alzheimer's disease and corticobasal degeneration presenting as corticobasal syndrome | Q48627120 |
| | Tau PET in Alzheimer disease and mild cognitive impairment. | Q48648902 |
| | Off-Target 18F-AV-1451 Binding in the Basal Ganglia Correlates with Age-Related Iron Accumulation. | Q51805345 |
| | Atypical progressive supranuclear palsy underlying progressive apraxia of speech and nonfluent aphasia. | Q53662290 |
| | Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Scale presentation and clinimetric testing results | Q57083753 |
| | Characterizing a neurodegenerative syndrome: primary progressive apraxia of speech | Q24632112 |
| | 11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment | Q24648319 |
| | Automated Anatomical Labeling of Activations in SPM Using a Macroscopic Anatomical Parcellation of the MNI MRI Single-Subject Brain | Q25855787 |
| | Clinicopathological correlations in corticobasal degeneration | Q28245070 |
| | Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B | Q29012704 |
| | The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment | Q29615678 |
| | Glial contributions to neurodegeneration in tauopathies | Q32173558 |
| | The FAB: a Frontal Assessment Battery at bedside. | Q33927821 |
| | Imaging correlates of pathology in corticobasal syndrome | Q34370058 |
| | The evolution of primary progressive apraxia of speech | Q34500103 |
| | Prediction of pathology in primary progressive language and speech disorders. | Q35014616 |
| | Tau positron emission tomographic imaging in aging and early Alzheimer disease | Q36535275 |
| | Criteria for the diagnosis of corticobasal degeneration | Q36661843 |
| | Validating novel tau positron emission tomography tracer [F-18]-AV-1451 (T807) on postmortem brain tissue | Q36987267 |
| | An autoradiographic evaluation of AV-1451 Tau PET in dementia | Q37001820 |
| | Clinicopathological and imaging correlates of progressive aphasia and apraxia of speech | Q37356674 |
| | Is the pathology of corticobasal syndrome predictable in life? | Q37522185 |
| | Defining imaging biomarker cut points for brain aging and Alzheimer's disease | Q38803637 |
| | Brain and Peripheral Atypical Inflammatory Mediators Potentiate Neuroinflammation and Neurodegeneration | Q41097407 |
| | In vivo retention of 18F-AV-1451 in corticobasal syndrome. | Q41591680 |
| | In vivo visualization of tau deposits in corticobasal syndrome by 18F-THK5351 PET. | Q42501142 |
| | Characterization of tau positron emission tomography tracer [18F]AV-1451 binding to postmortem tissue in Alzheimer's disease, primary tauopathies, and other dementias | Q42699490 |
| | [(18)F]T807, a novel tau positron emission tomography imaging agent for Alzheimer's disease | Q42712929 |
| | Early clinical PET imaging results with the novel PHF-tau radioligand [F-18]-T807. | Q45810537 |
| | Multimodal evaluation demonstrates in vivo 18F-AV-1451 uptake in autopsy-confirmed corticobasal degeneration | Q46936274 |
| | [18F]AV-1451 binding in vivo mirrors the expected distribution of TDP-43 pathology in the semantic variant of primary progressive aphasia. | Q47252490 |
| | Flortaucipir tau PET imaging in semantic variant primary progressive aphasia | Q47684719 |
| | 18F-AV-1451 binds to motor-related subcortical gray and white matter in corticobasal syndrome | Q47944653 |
| | Pathologic heterogeneity in clinically diagnosed corticobasal degeneration | Q48111354 |
| | Association of In Vivo [18F]AV-1451 Tau PET Imaging Results With Cortical Atrophy and Symptoms in Typical and Atypical Alzheimer Disease | Q48290101 |
| P433 | issue | 5 | |
| P921 | main subject | Corticobasal syndrome | Q55346059 |
| P304 | page(s) | 1079-1088 | |
| P577 | publication date | 2018-03-01 | |
| P1433 | published in | Journal of Neurology | Q6295649 |
| P1476 | title | [18F] AV-1451 uptake in corticobasal syndrome: the influence of beta-amyloid and clinical presentation | |
| P478 | volume | 265 | |